Biotechnology
This function is exclusive for Premium subscribers
-
DATABASE (121)
-
ARTICLES (104)
Ahmir Khalib Thompson, better known as Questlove, is an American DJ, songwriter and filmmaker. He is the drummer and joint frontman of the hip-hop band the Roots and has also made several appearances in movies and television. He has been also a musical director at the 2020 and 2021 Academy Awards ceremony. The plant-based food investor was reportedly behind President Barack Obama’s upcoming birthday celebration in 2021. Questlove has backed plant-based food companies Impossible Foods and NotCo.Also in 2021, Questlove directed a film about the 1969 Harlem Cultural Festival, the Summer of Soul (...Or, When the Revolution Could Not Be Televised), which won the US Grand Jury Prize and the Audience Award for documentary at the Sundance Film Festival.
Ahmir Khalib Thompson, better known as Questlove, is an American DJ, songwriter and filmmaker. He is the drummer and joint frontman of the hip-hop band the Roots and has also made several appearances in movies and television. He has been also a musical director at the 2020 and 2021 Academy Awards ceremony. The plant-based food investor was reportedly behind President Barack Obama’s upcoming birthday celebration in 2021. Questlove has backed plant-based food companies Impossible Foods and NotCo.Also in 2021, Questlove directed a film about the 1969 Harlem Cultural Festival, the Summer of Soul (...Or, When the Revolution Could Not Be Televised), which won the US Grand Jury Prize and the Audience Award for documentary at the Sundance Film Festival.
Cambridge Enterprise Venture Partners
A Cambridge-based investor, founded in 2006, that exists to support spin-off companies created at the city’s university with an emphasis on social impact. It currently has 57 companies in its portfolio, almost entirely in the areas of life and physical sciences, which have, in total, raised over £2bn in further investment and grant funding.Its most recent investments include in the June 2021 £3m seed round of Gallium Nitride semiconductor engineering company Porotech and in the January 2021 $20m Series A round of quantum computing innovators Riverlane.
A Cambridge-based investor, founded in 2006, that exists to support spin-off companies created at the city’s university with an emphasis on social impact. It currently has 57 companies in its portfolio, almost entirely in the areas of life and physical sciences, which have, in total, raised over £2bn in further investment and grant funding.Its most recent investments include in the June 2021 £3m seed round of Gallium Nitride semiconductor engineering company Porotech and in the January 2021 $20m Series A round of quantum computing innovators Riverlane.
Founded in London in 2009, Parkwalk is a specialist investor in deeptech spin-offs created at UK universities. Parkwalk currently has over £375m of assets under management and has invested in over 100 companies to date, emanating from the universities in Oxford, Cambridge, Imperial and Bristol, becoming the UK’s most active VC outside London. It currently has 143 portfolio companies, Its recent investments include the $17m May 2021 Series A round of cell therapy medtech Mogrify and in the April 2021 £1.9m seed round of HexagonFab, a medtech producing analytical lab instruments.
Founded in London in 2009, Parkwalk is a specialist investor in deeptech spin-offs created at UK universities. Parkwalk currently has over £375m of assets under management and has invested in over 100 companies to date, emanating from the universities in Oxford, Cambridge, Imperial and Bristol, becoming the UK’s most active VC outside London. It currently has 143 portfolio companies, Its recent investments include the $17m May 2021 Series A round of cell therapy medtech Mogrify and in the April 2021 £1.9m seed round of HexagonFab, a medtech producing analytical lab instruments.
Founded in Hong Kong in 2018, Lake Bleu Capital currently operates in both Hong Kong and Shanghai. With assets worth billions of US dollars under management, it mainly invests in pharmaceuticals, biotech, medical devices and healthcare services companies in Asia, especially Greater China. Its limited partners include sovereign wealth funds, university endowments, foundations, pension funds, and family offices across the world.With a long-term investment strategy, Lake Bleu Capital invests through both public and private equity with a focus on mid- to late-stage companies.
Founded in Hong Kong in 2018, Lake Bleu Capital currently operates in both Hong Kong and Shanghai. With assets worth billions of US dollars under management, it mainly invests in pharmaceuticals, biotech, medical devices and healthcare services companies in Asia, especially Greater China. Its limited partners include sovereign wealth funds, university endowments, foundations, pension funds, and family offices across the world.With a long-term investment strategy, Lake Bleu Capital invests through both public and private equity with a focus on mid- to late-stage companies.
Founded in 2017, Suzhou Longmen Ventures mainly invests in businesses working on innovative drugs and medical devices. It manages tens of billions RMB in assets.
Founded in 2017, Suzhou Longmen Ventures mainly invests in businesses working on innovative drugs and medical devices. It manages tens of billions RMB in assets.
Founded in 2018, Linden Asset Group currently has offices in Nanjing, Shenzhen and Singapore. With both US dollar- and RMB-denominated funds under management, it is focused on the fields of biotechnology, medtech and smart technology in the Asia Pacific region. Linden Asset prefers growth-stage startups that are cutting-edge in their respective areas and plans for overseas expansion.
Founded in 2018, Linden Asset Group currently has offices in Nanjing, Shenzhen and Singapore. With both US dollar- and RMB-denominated funds under management, it is focused on the fields of biotechnology, medtech and smart technology in the Asia Pacific region. Linden Asset prefers growth-stage startups that are cutting-edge in their respective areas and plans for overseas expansion.
With New Hope Group, one of China’s biggest agriculture and food businesses, as its cornerstone investor, HosenCare Brothers had operated as a PE arm within the group for nearly a decade. In 2017, it began to operate under its current name. It currently manages assets worth more than RMB 3bn, and mainly invests in sectors of medtech, healthcare, biotechnology and smart manufacturing.
With New Hope Group, one of China’s biggest agriculture and food businesses, as its cornerstone investor, HosenCare Brothers had operated as a PE arm within the group for nearly a decade. In 2017, it began to operate under its current name. It currently manages assets worth more than RMB 3bn, and mainly invests in sectors of medtech, healthcare, biotechnology and smart manufacturing.
Country Garden Venture Capital
Founded in 2019, Country Garden Venture Capital is the corporate venturing arm of Chinese real estate developer Country Garden. With its parent company as the cornerstone investor, it is focused on certain sectors of the supply chain, namely, technology, healthcare and consumption. As of March 2021, Country Garden Venture Capital has invested around RMB 10bn in over 50 companies with an average return above 80%. Among them, 15 have achieved unicorn status ($1bn in valuation), while four have successfully gone public.
Founded in 2019, Country Garden Venture Capital is the corporate venturing arm of Chinese real estate developer Country Garden. With its parent company as the cornerstone investor, it is focused on certain sectors of the supply chain, namely, technology, healthcare and consumption. As of March 2021, Country Garden Venture Capital has invested around RMB 10bn in over 50 companies with an average return above 80%. Among them, 15 have achieved unicorn status ($1bn in valuation), while four have successfully gone public.
Founded in 2018, Optimas Capital mainly invests in the medtech sector.
Founded in 2018, Optimas Capital mainly invests in the medtech sector.
Yangtze Delta Region Institute of Tsinghua University, Zhejiang
Yangtze Delta Region Research Institute of Tsinghua University, Zhejiang was co-founded by the provincial government of Zhejiang and Tsinghua University in 2003 for tech transfer. It has set up over 50 R&D platforms in the areas of life sciences, digital creativity, information technology and ecological environment and 11 offshore incubators in the US, UK, Germany and Australia. The institute manages over RMB 7.5bn of assets and also makes investments through its sub-funds with a total size of more than RMB 10bn. So far, it has incubated and invested in over 2,500 companies, 35 of whom have gone public or been acquired by listed companies.
Yangtze Delta Region Research Institute of Tsinghua University, Zhejiang was co-founded by the provincial government of Zhejiang and Tsinghua University in 2003 for tech transfer. It has set up over 50 R&D platforms in the areas of life sciences, digital creativity, information technology and ecological environment and 11 offshore incubators in the US, UK, Germany and Australia. The institute manages over RMB 7.5bn of assets and also makes investments through its sub-funds with a total size of more than RMB 10bn. So far, it has incubated and invested in over 2,500 companies, 35 of whom have gone public or been acquired by listed companies.
Founded in 2012, Purple Orange’s objective is to support the transition away from animals in the food chain, supporting early-stage food and biotech companies across the globe with a focus on alternative proteins and cellular agriculture. It currently has 12 startups from different nations in its portfolio. Its most recently disclosed investments have been in the December 2020 pre-seed round of Chinese cultured meat startup CellX and in the November 2020 $500,000 pre-seed round of Swedish plant-based food vending startup VEAT.
Founded in 2012, Purple Orange’s objective is to support the transition away from animals in the food chain, supporting early-stage food and biotech companies across the globe with a focus on alternative proteins and cellular agriculture. It currently has 12 startups from different nations in its portfolio. Its most recently disclosed investments have been in the December 2020 pre-seed round of Chinese cultured meat startup CellX and in the November 2020 $500,000 pre-seed round of Swedish plant-based food vending startup VEAT.
Founded in 2012 in San Francisco, Joyance invests in the “vectors of happiness” that it classifies as areas of science, including genetics and bioscience, the microbiome, neuroscience, virtual and augmented reality, and foodtech. It also invests in the area of social networking. Its investments are made through its management company, Ataraxia, and many have a European focus. It currently has 115 companies in its portfolio, with recent investments including in the August 2021 $3.6m seed round of Polish bionic limb manufacturer and in the July 2021 $8m Series A round of Israeli sports injury AI platform Zone7.
Founded in 2012 in San Francisco, Joyance invests in the “vectors of happiness” that it classifies as areas of science, including genetics and bioscience, the microbiome, neuroscience, virtual and augmented reality, and foodtech. It also invests in the area of social networking. Its investments are made through its management company, Ataraxia, and many have a European focus. It currently has 115 companies in its portfolio, with recent investments including in the August 2021 $3.6m seed round of Polish bionic limb manufacturer and in the July 2021 $8m Series A round of Israeli sports injury AI platform Zone7.
Royal Golden Eagle (RGE) is an industrial group owned by Indonesian tycoon Sukanto Tanoto. It employs 60,000 people worldwide with assets worth over $20bn. Tanoto started his business empire in 1967 as a supplier of spare parts to oil and construction companies in Indonesia. He went on to invest in oil palm plantations in 1979. Since 1985, his group companies have been managing 30,000 acres of oil palm trees each year across a total land area of 160,000 hectares.Headquartered in Singapore, RGE has interests in diverse sectors like paper palm oil, viscose, asset management, real estate, construction and energy. RGE owns the world’s largest viscose producer Sateri, Asia Pacific Rayon and energy firm Pacific Oil & Gas. It is also the owner of the Asia Pacific Resources International Holdings Limited (APRIL), one of the world’s largest pulp and paper mills. The Rainforest Action Network and other NGOs like Greenpeace and the WWF have put considerable pressure on the RGE group’s unsustainable operations such as the destruction of rainforests by APRIL. In 2019, RGE announced plans to invest $200m in cellulosic textile fiber research and development over a period of 10 years. Projects will include the scaling up of proven clean technology in fiber manufacturing, bringing pilot-scale production to commercial scale and R&D in emerging frontier solutions.
Royal Golden Eagle (RGE) is an industrial group owned by Indonesian tycoon Sukanto Tanoto. It employs 60,000 people worldwide with assets worth over $20bn. Tanoto started his business empire in 1967 as a supplier of spare parts to oil and construction companies in Indonesia. He went on to invest in oil palm plantations in 1979. Since 1985, his group companies have been managing 30,000 acres of oil palm trees each year across a total land area of 160,000 hectares.Headquartered in Singapore, RGE has interests in diverse sectors like paper palm oil, viscose, asset management, real estate, construction and energy. RGE owns the world’s largest viscose producer Sateri, Asia Pacific Rayon and energy firm Pacific Oil & Gas. It is also the owner of the Asia Pacific Resources International Holdings Limited (APRIL), one of the world’s largest pulp and paper mills. The Rainforest Action Network and other NGOs like Greenpeace and the WWF have put considerable pressure on the RGE group’s unsustainable operations such as the destruction of rainforests by APRIL. In 2019, RGE announced plans to invest $200m in cellulosic textile fiber research and development over a period of 10 years. Projects will include the scaling up of proven clean technology in fiber manufacturing, bringing pilot-scale production to commercial scale and R&D in emerging frontier solutions.
Mitchell Presser is a New York-based lawyer. He is currently co-chair of global law service Morrison & Foerster’s Global Corporate Department and a partner in the firm’s M&A and Private Equity group, advising on agriculture, amongst other areas. He previously was a founding partner of Paine Schwartz, a US-based $1.2 bn private equity firm specializing in sustainable food chain investing from 2006 to 2014. His sole disclosed angel investment to date was an undisclosed sum in the pre-seed funding of NovoNutrients, the US-based biotech producer of alt-protein from fermentation using CO2 and other emissions,
Mitchell Presser is a New York-based lawyer. He is currently co-chair of global law service Morrison & Foerster’s Global Corporate Department and a partner in the firm’s M&A and Private Equity group, advising on agriculture, amongst other areas. He previously was a founding partner of Paine Schwartz, a US-based $1.2 bn private equity firm specializing in sustainable food chain investing from 2006 to 2014. His sole disclosed angel investment to date was an undisclosed sum in the pre-seed funding of NovoNutrients, the US-based biotech producer of alt-protein from fermentation using CO2 and other emissions,
Bpifrance Large Venture is the growth equity arm of French state investor Bpifrance. It is a €1bn VC fund focused on high-growth, capital-intensive, innovative tech and life sciences companies that have already raised capital. It invests minority stakes of at least €10m as well as co-invests alongside current or new investors in rounds of at least about €20m. It has invested €600m to date and currently has 34 portfolio companies, including 18 listed ones.
Bpifrance Large Venture is the growth equity arm of French state investor Bpifrance. It is a €1bn VC fund focused on high-growth, capital-intensive, innovative tech and life sciences companies that have already raised capital. It invests minority stakes of at least €10m as well as co-invests alongside current or new investors in rounds of at least about €20m. It has invested €600m to date and currently has 34 portfolio companies, including 18 listed ones.
SWITCH Singapore 2021: How to harness the power of the deep tech ecosystem
Investor Jason Illian of Koch Disruptive Technologies talks talent, scaling for deep tech startups, and why longer gestation periods and mid-course pivots don’t have to be deal breakers
Yali Bio: Recreating a juicy steak in plant-based alternatives
Founded by the former head of Impossible Foods’ pilot plant, this Bay Area genomics and foodtech startup is one of the first to engineer a better fat for plant-based meat
QOA: Gourmet guilt-free chocolate, without the cocoa
Munich-based QOA transforms industrial food waste into vegan chocolate, enabling consumers to avoid the sustainability and ethical issues of cocoa production
Forget solar panels and batteries, Bioo wants to scale soil bioelectricity generation
Improving on NASA’s microbial fuel cell tech, Bioo hopes to boost crop efficiency and transform the way urbanites live, in future green cities powered by plants
Sequoia China Seed Fund: Growing an era of deep-tech startups
Managing Partner Neil Shen wants to help deep-tech and enterprise tech startups get investments more easily, across quantum computing, semiconductors, synthetic biology and more
South Summit 2021: Lessons in expanding to Asia from experts on the ground
Cast aside your Eurocentric mindsets, China-based SOSV’s Oscar Ramos and Brinc’s Heriberto Saldivar tell startups, why they should expand to the region, and how best to do it
South Summit 2021: Martin Varavsky, Leandro Sigman on post-Covid healthcare trends
Serial entrepreneur Martin Varavsky and Insud Pharma Chairman Leandro Sigman share their thoughts and projections on the future of health tech
Indonesian angel investor network ANGIN launches agrifood incubator
Program targets ESG investment and builds on the strong potential of Indonesia’s agriculture sector, which kept growing despite the Covid-19 pandemic
Smart Agrifood 2021: SVG Ventures's Hartnett, Land O'Lakes's Bekele on disruption in agrifood chain
How US farming cooperative Land O'Lakes and leading CPG brands are working with famers and tech firms to overcome agritech challenges, transform the whole value chain
Smart Agrifood Summit 2021: A global innovation ecosystem is needed to catch up with other sectors
Investors from SVG Ventures/THRIVE, Pinduoduo and others agree that players must join forces to boost agrifood tech investment, internationally and across the value chain
Forward Fooding: Ranking the world's agrifood startups on success and sustainability
The collaborative platform has opened applications for its FoodTech500 global ranking of agrifood startups; counts over 7,000 startups and scaleups mapped so far
Good Startup: Alt-protein products can be better than real meat
The investor of Eat Just, Ripple Foods and more expects its portfolio companies will exit in the next four to six years, mostly through acquisition
Beyond Leather Materials: Turning apples into alt-leather for sustainable fashion
Through its Leap brand, the Danish startup cuts food waste by turning apples junked in cider factories into affordable vegan leather for the $100bn leather market
Meatable joins Royal DSM to create growth media specific for cell-based meat tech
The R&D between the biotech startup and fellow Dutch nutrition conglomerate could help scale and drive the commercial viability of lab-grown meat
NovoNutrients: Tackling the dual problems of CO2 emissions and over-fishing
The first to transform CO2 to fish food, NovoNutrients is trialing with industry giants Skretting and Chevron, and will soon raise Series A funding
Search instead for portugal, b2b, hospitality
POPULAR DATABASE
